Rudmer Postma

Dr. Rudmer Postma

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2023 in Gastro Hep Advances
Verified
Journal Article
Open access
RPRudmer Postma
Rudmer Postma
ABAnnelotte G.C. Broekhoven
Annelotte G.C. Broekhoven
HVHein W. Verspaget
Hein W. Verspaget
HBHetty de Boer
Hetty de Boer
THThomas Hankemeier
Thomas Hankemeier
AZAnton Jan van Zonneveld
Anton Jan van Zonneveld
Endothelial cell (EC) dysfunction in response to circulating plasma factors is a known causal factor in many systemic diseases. However, no appropriate assay is available to investigate this causality ex vivo. In liver cirrhosis, systemic inflammation is identified as central mechanism in progression from compensated to decompensated cirrhosis (DC), but the role of ECs therein is unknown. We aimed to develop a novel ex vivo assay for assessing EC responses to patient-derived plasma (PDP) and assess the potential of this assay in a cohort of liver cirrhosis patients. Image-based morphological profiling was utilized to assess the impact of PDP on cultured ECs. Endothelial cell (EC) monolayers were exposed to 25% stabilized PDP (20 compensated cirrhoses, 20 DCs, and 20 healthy controls (HCs). Single-cell morphological profiles were extracted by automated image-analysis following staining of multiple cellular components and high-content imaging. Patient profiles were created by dimension reduction and cell-to-patient data aggregation, followed by multivariate-analysis to stratify patients and identify discriminating features. Patient-derived plasma (PDP) exposure induced profound changes in EC morphology, displaying clear differences between controls and DC patients. Compensated cirrhosis patients showed overlap with healthy controls and DC patients. Supervised analysis showed Child-Pugh (CP) class could be predicted from EC morphology. Most importantly, CP-C patients displayed distinct EC phenotypes, in which mitochondrial changes were most discriminative. Morphological profiling presents a viable tool to assess the endothelium ex vivo. We demonstrated that the EC phenotype corresponds with disease severity in liver cirrhosis. Moreover, our results suggest the presence of mitochondrial dysfunction in ECs of CP-C patient.

13 June 2024 in Materials Today Bio
Verified
Journal Article
Open access
ZXZhuotao Xiao
Zhuotao Xiao
RPRudmer Postma
Rudmer Postma
AZAnton Jan van Zonneveld
Anton Jan van Zonneveld
BBBernard M. van den Berg
Bernard M. van den Berg
WSWendy M.P.J. Sol
Wendy M.P.J. Sol
JRJoris I. Rotmans
Joris I. Rotmans
Disturbed flow is one of the pathological initiators of endothelial dysfunction in intimal hyperplasia (IH) which is commonly seen in vascular bypass grafts, and arteriovenous fistulas. Various in vitro disease models have been designed to simulate the hemodynamic conditions found in the vasculature. Nonetheless, prior investigations have encountered challenges in establishing a robust disturbed flow model, primarily attributed to the complex bifurcated geometries and distinctive flow dynamics. In the present study, we aim to address this gap by introducing an in vitro bypass flow model capable of inducing disturbed flow and other hemodynamics patterns through a pulsatile flow in the same model. To assess the model's validity, we employed computational fluid dynamics (CFD) to simulate hemodynamics and compared the morphology and functions of human umbilical venous endothelial cells (HUVECs) under disturbed flow conditions to those in physiological flow or stagnant conditions. CFD analysis revealed the generation of disturbed flow within the model, pinpointing the specific location in the channel where the effects of disturbed flow were observed. High-content screening, a single-cell morphological profile assessment, demonstrated that HUVECs in the disturbed flow area exhibited random orientation, and morphological features were significantly distinct compared to cells in the physiological flow or stagnant condition after a two days of flow exposure. Furthermore, HUVECs exposed to disturbed flow underwent extensive remodeling of the adherens junctions and expressed higher levels of endothelial cell activation markers compared to other hemodynamic conditions. In conclusion, our in vitro bypass flow model provides a robust platform for investigating the associations between disturbed flow pattern and vascular diseases.

6 January 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RPRudmer Postma
Rudmer Postma
SFSusan E Fischer
Susan E Fischer
RBRoel Bijkerk
Roel Bijkerk
AZAnton Jan van Zonneveld
Anton Jan van Zonneveld
Background: Systemic diseases are often associated with endothelial cell (EC) dysfunction. A key function of ECs is to maintain the barrier between the blood and the interstitial space. The integrity of the endothelial cell barrier is maintained by VE-Cadherin homophilic interactions between adjacent cells. The morphology of these borders is highly dynamic and can be actively remodeled by numerous drivers in a (patho)physiologic context specific fashion. Objectives: High-content screening of the impact of circulatory factors on the morphology of VE-Cadherin borders in endothelial monolayers in vitro will enable the assessment of the progression of systemic vascular disease. We therefore aimed to create an image analysis pipeline, capable of automatically analyzing images from large scale screenings, both capturing all VE-cadherin phenotypes present in a sample while preserving the higher-level 2D structure. Our pipeline is aimed at creating 1D tensor representations of the VE-cadherin adherence junction structure and negate the need for normalization. Method: An image analysis pipeline, with at the center a convolution neural network was developed. The deep neural network was trained using examples of distinct VE-Cadherin morphologies from many experiments. The generalizability of the model was extensively tested in independent experiments, before further validation using ECs exposed ex vivo to plasma from patients with liver cirrhosis and proven vascular complications. Results: Our workflow was able to detect and stratify many of the different VE-Cadherin morphologies present within the datasets and produced similar results within independent experiments, proving the generality of the model. Finally, by EC-cell border morphology profiling, our pipeline enabled the stratification of liver cirrhosis patients and associated patient-specific morphological cell border changes to responses elicited by known inflammatory factors. Conclusion: We developed an image analysis pipeline, capable of intuitively and robustly stratifying all VE-Cadherin morphologies within a sample. Subsequent VE-Cadherin morphological profiles can be used to compare between stimuli, small molecule screenings, or assess disease progression.

20 April 2026 in Liver International
Verified
Journal Article
Open access
SFSusan E. Fischer
Susan E. Fischer
RPRudmer Postma
Rudmer Postma
RBRoel Bijkerk
Roel Bijkerk
AKAnnarein J. C. Kerbert
Annarein J. C. Kerbert
AZAnton Jan van Zonneveld
Anton Jan van Zonneveld
MCMinneke J. Coenraad
Minneke J. Coenraad
Background & Aims: Endothelial cell (EC) activation is a critical driver of disease progression in cirrhosis, contributing to acute decompensation (AD) and acute‐on‐chronic liver failure (ACLF). Although human albumin administration improves EC function in cirrhotic patients with hypoalbuminemia, its direct effects on ECs remain unclear. This ex vivo study investigates the impact of albumin on EC morphology and mitochondrial function upon exposure to plasma from patients with decompensated cirrhosis (DC). Methods: Human umbilical vein ECs were exposed to plasma from patients with DC and hypoalbuminemia (albumin < 30 g/L, n = 20), compensated cirrhosis (CC, > 30 g/L, n = 20), or healthy controls (HC, n = 20). Albumin was added to DC and HC plasma to reach physiological (~40 g/L) or supraphysiological levels. Mitochondrial function was assessed by measuring oxygen consumption rate (OCR) and reactive oxygen species (ROS) production. The effects of albumin on EC activation were tested using circulating factors elevated in DC (lipopolysaccharide (LPS), tumour necrosis factor‐α (TNFα), bilirubin). Results: Mitochondrial morphology distinguished ECs exposed to DC plasma from those exposed to CC or HC plasma. Albumin supplementation shifted EC morphology towards a healthier phenotype. ECs exposed to DC plasma showed increased mitochondrial respiration without a concomitant increase in ROS production, which was normalised by albumin. Albumin had no significant effects on EC activation induced by circulating factors. Conclusions: Plasma from patients with DC and hypoalbuminemia induces EC morphological changes, particularly in mitochondria. Albumin mitigates these effects, suggesting a direct modulatory role on mitochondrial function and supporting its therapeutic potential in vascular dysfunction in cirrhosis.

31 August 2025 in Cells
Verified
Journal Article
Open access
PDF file
OPOlga Papazisi
Olga Papazisi
RPRudmer Postma
Rudmer Postma
RDRichard Dirven
Richard Dirven
SBSaskia L.M.A. Beeres
Saskia L.M.A. Beeres
RBRemco Berendsen
Remco Berendsen
AZAnton-Jan van Zonneveld
Anton-Jan van Zonneveld
Patients with heart failure with a reduced ejection fraction (HFrEF) are at an increased risk of developing postoperative hemodynamic instability and vasoplegia after surgery on cardiopulmonary bypass (CPB). Potentially pre-existing endothelial cell (EC) alterations due to chronic HF influence EC responses to cardiac surgery and might be responsible for the altered vascular responsiveness observed postoperatively. In this study, well-described EC activation markers were measured in blood samples collected pre- and perioperatively at four time points from HFrEF and control patients undergoing cardiac surgery on cardiopulmonary bypass (CPB). Circulating levels of Angiopoietin 2 (ANG2), von Willebrand Factor (vWF), and soluble P-selectin were measured using ELISA. Additionally, we investigated the responses of the cultured EC to patient-derived plasma through morphological profiling and mitochondrial functional assays. In total, 36 patients were included (67 (61–71) years, 78% male). HFrEF patients had higher baseline ANG2 and vWF levels when compared to controls. Both markers peaked during the first postoperative day. A pronounced increase in vWF was seen in controls after CPB. Ex vivo EC responses to patient-derived plasma showed distinct morphological differences between the two groups at baseline. A mitochondrial analysis indicated alterations in function and morphology for both groups after CPB. In conclusion, HFrEF patients exhibit a dampened EC response to cardiac surgery on CPB. Stable circulating factors in HFrEF plasma are responsible for inducing EC stress. Moreover, the mitochondrial function is highly affected postoperatively. This pre-existing mitochondrial and EC dysfunction predispose HFrEF patients to postoperative hemodynamic instability.

18 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
JKJuliette A de Klerk
Juliette A de Klerk
RSRoderick Slieker
Roderick Slieker
WPWilson C Parker
Wilson C Parker
HWHaojia Wu
Haojia Wu
YMYoshiharu Muto
Yoshiharu Muto
RBRoel Bijkerk
Roel Bijkerk
Background: Long non-coding RNAs (lncRNAs) play essential roles in cellular processes, often exhibiting cell type-specific expression and influencing kidney function. While single-cell RNA sequencing (scRNA-seq) has advanced our understanding of cellular specificity, past studies focus solely on protein-coding genes. We hypothesize that lncRNAs, due to their cell-specific nature, have crucial functions within particular renal cells and thereby play essential roles in renal cell function and disease. Methods: Using single-nucleus RNA sequencing (snRNA-seq) data from kidney samples of five healthy individuals and six DKD patients, we explored the non-coding transcriptome. Cell type-specific lncRNAs were identified, and their differential expression in DKD was assessed. Integrative analyses included expression quantitative trait loci (eQTL), genome-wide association studies (GWAS) for estimated glomerular filtration rate (eGFR), and gene regulatory networks. Functional studies focused on TARID , a lncRNA with podocyte-specific expression, to elucidate its role in podocyte health. Results: we identified 349 lncRNAs with cell type-specific expression across kidney cell types. Of these, 104 lncRNAs were differentially expressed in DKD. Integrative analyses, including eQTL data, GWAS results for eGFR and gene regulatory networks, pinpointed TARID , a podocyte-specific lncRNA, as a key candidate upregulated in DKD. Functional studies confirmed TARID ’s podocyte-specific expression and revealed its central role in actin cytoskeleton reorganization, a critical process in podocyte health. Conclusions: Our study provides a comprehensive resource of single-cell lncRNA expression in the human kidney and highlights the importance of cell type-specific lncRNAs in kidney function and disease. Specifically, we demonstrate the functional relevance of TARID in podocyte health. This work underscores the utility of integrating scRNA-seq with functional genomics to uncover novel regulatory mechanisms in kidney biology. Key points: This provides a resource for kidney (cell type-specific) lncRNA expression and demonstrates the importance of lncRNAs in renal health. We identified 349 cell type-specific lncRNAs in the human kidney, with 104 showing altered expression in diabetic kidney disease (DKD). TARID , a podocyte-specific lncRNA upregulated in DKD, is crucial for actin cytoskeleton reorganization in podocytes.